FDA 483 - Reproductive Care Center - May 14, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Reproductive Care Center in Sandy, UT, a human tissue reproductive establishment, revealed significant deficiencies in donor screening and eligibility determinations. The firm was cited for deeming HCT/P donors eligible despite identified risk factors for communicable diseases and for determining donor eligibility prior to the completion of required donor history questionnaires. These issues indicate a failure to ensure the safety and suitability of donor materials.
ID · d1e19619-c16e-49d2-9da7-106f643511d0